Lista de obras - Giuseppe Giannini - Dominio Público Uruguay

A lymphotactin-producing monoclonal T-cell lymphoproliferative disorder with extreme lymphocytopenia and progressive leukoencephalopathy

artículo científico publicado en 2006

Activation of three distinct RXR/RAR heterodimers induces growth arrest and differentiation of neuroblastoma cells

scientific article published on 01 October 1997

An integrated approach identifies Nhlh1 and Insm1 as Sonic Hedgehog-regulated genes in developing cerebellum and medulloblastoma

artículo científico publicado en 2008

Association of SULT1A1 Arg²¹³His polymorphism with male breast cancer risk: results from a multicenter study in Italy.

artículo científico publicado en 2014

Association of low-penetrance alleles with male breast cancer risk and clinicopathological characteristics: results from a multicenter study in Italy.

artículo científico publicado en 2013

Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer

artículo científico publicado en 2015

Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2014

BRCA1/BRCA2 mutation status and clinical-pathologic features of 108 male breast cancer cases from Tuscany: a population-based study in central Italy

article

BRCA1/BRCA2 rearrangements and CHEK2 common mutations are infrequent in Italian male breast cancer cases

article

Candidate genetic modifiers for breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2014

Chromosomal localization of murine ryanodine receptor genes RYR1, RYR2, and RYR3 by in situ hybridization.

artículo científico publicado en 1994

Circulating tumor cells: exploring intratumor heterogeneity of colorectal cancer

artículo científico publicado en 2014

Clinical and pathologic characteristics of BRCA-positive and BRCA-negative male breast cancer patients: results from a collaborative multicenter study in Italy

article

Clinical classification of BRCA1 DNA missense variants: H1686Q is a novel pathogenic mutation occurring in the ontogenetically invariant THV motif of the N-terminal BRCT domain

artículo científico publicado en 2008

Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2011

Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2012

Delayed and defective anti-HIV IgM response in infants

scientific article published on 01 March 1987

Direct correlation between double K-RAS mutation and mucinous carcinoma. A case report.

artículo científico publicado en 2015

Does the search for large genomic rearrangements impact BRCAPRO carrier prediction?

scientific article published on 01 June 2007

Drug treatment in the development of mismatch repair defective acute leukemia and myelodysplastic syndrome.

artículo científico publicado en 2003

Epigenetic siRNA and Chemical Screens Identify SETD8 Inhibition as a Therapeutic Strategy for p53 Activation in High-Risk Neuroblastoma

artículo científico publicado en 2017

Galectin-3 impairment of MYCN-dependent apoptosis-sensitive phenotype is antagonized by nutlin-3 in neuroblastoma cells

artículo científico publicado en 2012

Galectin-3 is a marker of favorable prognosis and a biologically relevant molecule in neuroblastic tumors.

scientific article published on 06 March 2014

Genome-wide association study identifies a common variant in RAD51B associated with male breast cancer risk

artículo científico publicado en 2012

HE4 in the differential diagnosis of a pelvic mass: a case report.

artículo científico publicado en 2011

Human papilloma virus-dependent HMGA1 expression is a relevant step in cervical carcinogenesis

artículo científico publicado en 2008

Improving the accuracy of BRCA1/2 mutation prediction: validation of the novel country-customized IC software

scientific article published on 01 January 2006

Insight into genetic susceptibility to male breast cancer by multigene panel testing: Results from a multicenter study in Italy

scientific article published on 24 January 2019

International distribution and age estimation of the Portuguese BRCA2 c.156_157insAlu founder mutation.

artículo científico publicado en 2010

Localization of a novel ryanodine receptor gene (RYR3) to human chromosome 15q14-q15 by in situ hybridization.

artículo científico publicado en 1993

MRE11 expression is impaired in gastric cancer with microsatellite instability.

artículo científico publicado en 2004

MYCN sensitizes human neuroblastoma to apoptosis by HIPK2 activation through a DNA damage response.

artículo científico publicado en 2010

Metastatic colorectal cancer first-line treatment with bevacizumab: the impact of K-ras mutation

artículo científico publicado en 2013

MiR-128 up-regulation inhibits Reelin and DCX expression and reduces neuroblastoma cell motility and invasiveness.

artículo científico publicado en 2009

Molecular mechanism of HMGA1 deregulation in human neuroblastoma.

artículo científico publicado en 2005

Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer

artículo científico publicado en 2013

NF-kappaB, and not MYCN, regulates MHC class I and endoplasmic reticulum aminopeptidases in human neuroblastoma cells

artículo científico publicado en 2010

New mutations and protein variants of NBS1 are identified in cancer cell lines

scientific article published on 01 February 2003

Novel and known genetic variants for male breast cancer risk at 8q24.21, 9p21.3, 11q13.3 and 14q24.1: results from a multicenter study in Italy

artículo científico publicado en 2015

Novel and recurrent BRCA2 mutations in Italian breast/ovarian cancer families widen the ovarian cancer cluster region boundaries to exons 13 and 14.

artículo científico publicado en 2014

Numb is a suppressor of Hedgehog signalling and targets Gli1 for Itch-dependent ubiquitination

artículo científico publicado en 2006

Optimizing the identification of risk-relevant mutations by multigene panel testing in selected hereditary breast/ovarian cancer families.

artículo científico publicado en 2017

PALB2 mutations in male breast cancer: a population-based study in Central Italy

article

PCAF ubiquitin ligase activity inhibits Hedgehog/Gli1 signaling in p53-dependent response to genotoxic stress

artículo científico publicado en 2013

PRDX1 and PRDX6 are repressed in papillary thyroid carcinomas via BRAF V600E-dependent and -independent mechanisms.

artículo científico publicado en 2013

Prevalence of BRCA1 and BRCA2 genomic rearrangements in a cohort of consecutive Italian breast and/or ovarian cancer families

artículo científico publicado en 2007

The BRCAPRO 5.0 model is a useful tool in genetic counseling and clinical management of male breast cancer cases

artículo científico publicado en 2010

The CASP8 rs3834129 polymorphism and breast cancer risk in BRCA1 mutation carriers

artículo científico publicado en 2010

The HMGA1 protoncogene frequently deregulated in cancer is a transcriptional target of E2F1.

artículo científico publicado en 2012

The MRN complex is transcriptionally regulated by MYCN during neural cell proliferation to control replication stress.

artículo científico publicado en 2015

The coactivator CRTC1 promotes cell proliferation and transformation via AP-1

scholarly article

The ryanodine receptor/calcium channel genes are widely and differentially expressed in murine brain and peripheral tissues.

artículo científico publicado en 1995

Validation of the Ion Torrent PGM sequencing for the prospective routine molecular diagnostic of colorectal cancer

artículo científico publicado en 2015

Vemurafenib and panitumumab combination tailored therapy in BRAF-mutated metastatic colorectal cancer: a case report.

artículo científico publicado en 2014

cDNA cloning reveals a tissue specific expression of alternatively spliced transcripts of the ryanodine receptor type 3 (RyR3) calcium release channel

artículo científico publicado en 1996

Lista de obras de Giuseppe Giannini

A lymphotactin-producing monoclonal T-cell lymphoproliferative disorder with extreme lymphocytopenia and progressive leukoencephalopathy

Activation of three distinct RXR/RAR heterodimers induces growth arrest and differentiation of neuroblastoma cells

An integrated approach identifies Nhlh1 and Insm1 as Sonic Hedgehog-regulated genes in developing cerebellum and medulloblastoma

Association of SULT1A1 Arg²¹³His polymorphism with male breast cancer risk: results from a multicenter study in Italy.

Association of low-penetrance alleles with male breast cancer risk and clinicopathological characteristics: results from a multicenter study in Italy.

Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer

Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers

BRCA1/BRCA2 mutation status and clinical-pathologic features of 108 male breast cancer cases from Tuscany: a population-based study in central Italy

BRCA1/BRCA2 rearrangements and CHEK2 common mutations are infrequent in Italian male breast cancer cases

Candidate genetic modifiers for breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers

Chromosomal localization of murine ryanodine receptor genes RYR1, RYR2, and RYR3 by in situ hybridization.

Circulating tumor cells: exploring intratumor heterogeneity of colorectal cancer

Clinical and pathologic characteristics of BRCA-positive and BRCA-negative male breast cancer patients: results from a collaborative multicenter study in Italy

Clinical classification of BRCA1 DNA missense variants: H1686Q is a novel pathogenic mutation occurring in the ontogenetically invariant THV motif of the N-terminal BRCT domain

Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers

Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers

Delayed and defective anti-HIV IgM response in infants

Direct correlation between double K-RAS mutation and mucinous carcinoma. A case report.

Does the search for large genomic rearrangements impact BRCAPRO carrier prediction?

Drug treatment in the development of mismatch repair defective acute leukemia and myelodysplastic syndrome.

Epigenetic siRNA and Chemical Screens Identify SETD8 Inhibition as a Therapeutic Strategy for p53 Activation in High-Risk Neuroblastoma

Galectin-3 impairment of MYCN-dependent apoptosis-sensitive phenotype is antagonized by nutlin-3 in neuroblastoma cells

Galectin-3 is a marker of favorable prognosis and a biologically relevant molecule in neuroblastic tumors.

Genome-wide association study identifies a common variant in RAD51B associated with male breast cancer risk

HE4 in the differential diagnosis of a pelvic mass: a case report.

Human papilloma virus-dependent HMGA1 expression is a relevant step in cervical carcinogenesis

Improving the accuracy of BRCA1/2 mutation prediction: validation of the novel country-customized IC software

Insight into genetic susceptibility to male breast cancer by multigene panel testing: Results from a multicenter study in Italy

International distribution and age estimation of the Portuguese BRCA2 c.156_157insAlu founder mutation.

Localization of a novel ryanodine receptor gene (RYR3) to human chromosome 15q14-q15 by in situ hybridization.

MRE11 expression is impaired in gastric cancer with microsatellite instability.

MYCN sensitizes human neuroblastoma to apoptosis by HIPK2 activation through a DNA damage response.

Metastatic colorectal cancer first-line treatment with bevacizumab: the impact of K-ras mutation

MiR-128 up-regulation inhibits Reelin and DCX expression and reduces neuroblastoma cell motility and invasiveness.

Molecular mechanism of HMGA1 deregulation in human neuroblastoma.

Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer

NF-kappaB, and not MYCN, regulates MHC class I and endoplasmic reticulum aminopeptidases in human neuroblastoma cells

New mutations and protein variants of NBS1 are identified in cancer cell lines

Novel and known genetic variants for male breast cancer risk at 8q24.21, 9p21.3, 11q13.3 and 14q24.1: results from a multicenter study in Italy

Novel and recurrent BRCA2 mutations in Italian breast/ovarian cancer families widen the ovarian cancer cluster region boundaries to exons 13 and 14.

Numb is a suppressor of Hedgehog signalling and targets Gli1 for Itch-dependent ubiquitination

Optimizing the identification of risk-relevant mutations by multigene panel testing in selected hereditary breast/ovarian cancer families.

PALB2 mutations in male breast cancer: a population-based study in Central Italy

PCAF ubiquitin ligase activity inhibits Hedgehog/Gli1 signaling in p53-dependent response to genotoxic stress

PRDX1 and PRDX6 are repressed in papillary thyroid carcinomas via BRAF V600E-dependent and -independent mechanisms.

Prevalence of BRCA1 and BRCA2 genomic rearrangements in a cohort of consecutive Italian breast and/or ovarian cancer families

The BRCAPRO 5.0 model is a useful tool in genetic counseling and clinical management of male breast cancer cases

The CASP8 rs3834129 polymorphism and breast cancer risk in BRCA1 mutation carriers

The HMGA1 protoncogene frequently deregulated in cancer is a transcriptional target of E2F1.

The MRN complex is transcriptionally regulated by MYCN during neural cell proliferation to control replication stress.

The coactivator CRTC1 promotes cell proliferation and transformation via AP-1

The ryanodine receptor/calcium channel genes are widely and differentially expressed in murine brain and peripheral tissues.

Validation of the Ion Torrent PGM sequencing for the prospective routine molecular diagnostic of colorectal cancer

Vemurafenib and panitumumab combination tailored therapy in BRAF-mutated metastatic colorectal cancer: a case report.

cDNA cloning reveals a tissue specific expression of alternatively spliced transcripts of the ryanodine receptor type 3 (RyR3) calcium release channel